We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOV icon
3501
PUT
NOV
NOV
$7.54B
$5.96M ﹤0.01%
285,200
+91,200
+47% +$1.91M
CUK
3502
DELISTED
Carnival PLC
CUK
$5.95M ﹤0.01%
827,617
-643,960
-44% -$4.96M
RXRX icon
3503
Recursion Pharmaceuticals
RXRX
$1.69B
$5.95M ﹤0.01%
771,150
+269,280
+54% +$2.64M
TRP icon
3504
PUT
TC Energy
TRP
$66.7B
$5.94M ﹤0.01%
149,100
+103,100
+224% +$4.47M
FULC icon
3505
Fulcrum Therapeutics
FULC
$285M
$5.94M ﹤0.01%
816,244
+174,112
+27% +$1.14M
AHCO icon
3506
AdaptHealth
AHCO
$775M
$5.93M ﹤0.01%
308,529
-101,789
-25% -$2.15M
MRTX
3507
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.93M ﹤0.01%
130,800
+52,100
+66% +$3.37M
PRKS icon
3508
CALL
United Parks & Resorts
PRKS
$2.04B
$5.91M ﹤0.01%
110,500
-28,800
-21% -$1.54M
ICPT
3509
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.9M ﹤0.01%
477,129
+114,068
+31% +$1.62M
LNTH icon
3510
CALL
Lantheus
LNTH
$6.59B
$5.9M ﹤0.01%
115,800
-123,200
-52% -$7.6M
HNI icon
3511
HNI Corp
HNI
$3.53B
$5.9M ﹤0.01%
207,556
+18,907
+10% +$538K
LMBS icon
3512
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
$5.9M ﹤0.01%
124,457
+76,470
+159% +$3.61M
VEA icon
3513
CALL
Vanguard FTSE Developed Markets ETF
VEA
$239B
$5.9M ﹤0.01%
140,500
+61,000
+77% +$2.47M
VYX icon
3514
NCR Voyix
VYX
$1.13B
$5.9M ﹤0.01%
410,486
-980,787
-70% -$13M
DFEN icon
3515
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$441M
$5.89M ﹤0.01%
295,998
+141,599
+92% +$2.51M
DTE icon
3516
PUT
DTE Energy
DTE
$29.3B
$5.89M ﹤0.01%
50,100
-61,000
-55% -$6.92M
RETA
3517
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.88M ﹤0.01%
154,900
+29,900
+24% +$1.03M
SPYV icon
3518
CALL
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
$5.88M ﹤0.01%
151,300
-27,000
-15% -$1.03M
CBRL icon
3519
PUT
Cracker Barrel
CBRL
$1.29B
$5.88M ﹤0.01%
62,100
-65,100
-51% -$6.78M
CRUS icon
3520
CALL
Cirrus Logic
CRUS
$6.07B
$5.88M ﹤0.01%
78,900
-171,200
-68% -$12.3M
PFG icon
3521
PUT
Principal Financial Group
PFG
$24.4B
$5.87M ﹤0.01%
70,000
+47,200
+207% +$4.05M
KAI icon
3522
Kadant
KAI
$3.95B
$5.87M ﹤0.01%
33,032
+16,461
+99% +$2.93M
PVH icon
3523
CALL
PVH
PVH
$3.8B
$5.86M ﹤0.01%
83,000
-66,500
-44% -$3.96M
MTZ icon
3524
CALL
MasTec
MTZ
$23.9B
$5.86M ﹤0.01%
68,648
+18,848
+38% +$1.55M
AXTA icon
3525
CALL
Axalta
AXTA
$7.99B
$5.85M ﹤0.01%
229,500
-79,400
-26% -$1.96M

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.